Quasi-experiments to establish causal effects of HIV care and treatment and to improve the cascade of care

Current Opinion in HIV and AIDS

Volumn 10, Issue 6, 2015, Pages 495-501

  Bor, Jacob ^a,b   Geldsetzer, Pascal ^c   Venkataramani, Atheendar ^d   Bärnighausen, Till ^c,e  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e AFRICA HEALTH RESEARCH INSTITUTE   (South Africa)

Author keywords

Cascade of care; Causal inference; HIV AIDS; Natural experiment; Quasi experiment

Indexed keywords

CASCADE OF CARE; EXTERNAL VALIDITY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENTION TO TREAT ANALYSIS; INTERNAL VALIDITY; MENDELIAN RANDOMIZATION ANALYSIS; OBSERVATIONAL STUDY; PATIENT CARE; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESOURCE ALLOCATION; REVIEW; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; HEALTH SERVICES RESEARCH; HIV INFECTIONS; METHODOLOGY; PROCEDURES; TREATMENT OUTCOME;

HEALTH SERVICES RESEARCH; HIV INFECTIONS; HUMANS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 84943769420     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0000000000000191     Document Type: Review

References (63)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study. Lancet 2012; 380:2095-2128.
2. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med 2011; 8:e1001056. doi:10.1371/journal.pmed.1001056.
3. Fauci AS. AIDS: let science inform policy. Science 2011; 333:13. doi:10.1126/science.1209751.
4. Meyer BD. Natural and quasi-experiments in economics. J Bus Econ Stat 1995; 13:151-161.
5. King G, Keohane RO, Verba S. The importance of research design. Rethink Soc Inq Divers Tools, Shar Stand. United Nations Publications; 2004; 181-192.
6. Angrist JD & Pischke JS. Mastering 'metrics: the path from cause to effect. Princeton University Press, 2014.
7. Angrist JD & Pischke JS. Mostly harmless econometrics: an empiricist's companion. Princeton University Press, 2009.
8. Thistlethwaite DL, Campbell DT. Regression-discontinuity analysis: an alternative to the ex post facto experiment. J Educ Psychol 1960; 51:309-317.
9. Lee DS, Lemieux T. Regression discontinuity designs in economics. J Econ Lit 2010; 48:281-355.
10. Bor J, Moscoe E, Mutevedzi P, et al. Regression discontinuity designs in epidemiology: causal inference without randomized trials. Epidemiology 2014; 25:729-737.
11. Imbens GW, Angrist JD. Identification and estimation of local average treatment effects. Econometrica 1994; 62:467-475.
12. Hernán MA, Robins JM. Instruments for causal inference: an epidemiologist's dream? Epidemiology 2006; 17:360-372.
13. Hearst N, Newman TB, Hulley SB. Delayed effects of the military draft on mortality.Arandomized natural experiment. N Engl J Med 1986;314:620-624.
14. Hearst N, Buehler JW, Newman TB, Rutherford GW. The draft lottery and AIDS: evidence against increased intravenous drug use by Vietnam-era veterans. Am J Epidemiol 1991; 134:522-525.
15. Lawlor DA, Harbord RM, Sterne JAC, et al. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008; 27:1133-1163.
16. Shadish WR, Cook TD, Campbell DT. Experimental and quasi-experimental d. esigns for generalized causal inference. Boston, MA: Houghton Mifflin; 2002
17. Gunasekara FI, Richardson K, Carter K, Blakely T. Fixed effects analysis of repeated measures data. Int J Epidemiol 2014; 43:264-269.
18. Rockers PC, Røttingen J-A, Shemilt I, et al. Inclusion of quasi-experimental studies in systematic reviews of health systems research. Health Policy (New York) 2015; 119:511-521.
19. Baranov V, Bennett D, Kohler H-P. The Indirect Impact of Antiretroviral Therapy [Internet]. 2012. Report No.: 12-08. http://repository.upenn.edu/cgi/viewcontent.cgi?article=1038&context=psc-working-papers.
20. Wilson N. Antiretroviral Therapy and Demand for HIV Testing: Evidence from Zambia. 2011 Available at SSRN: http://ssrn.com/abstract=1982185 or http://dx.doi.org/10.2139/ssrn.1982185.
21. Bendavid E, Holmes CB, Bhattacharya J, Miller G. HIV development assistance and adult mortality in Africa. JAMA Am Med Assoc 2012; 307:2060-2067. doi:10.1001/jama.2012.2001.
22. Bor J, Herbst A, Newell M, Bärnighausen T. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science 2013; 339:961-965.
23. Bor J, Moscoe E, Bärnighausen T. When to start HIV treatment: evidence from a regression discontinuity study in South Africa. San Diego, CA: Population Association of America Annual Meeting; 2015; http://paa2015.princeton.e-du/abstracts/151012.
24. Lucas AM, Wilson NL. Can Antiretroviral Therapy at Scale Improve the Health of the Targeted in Sub-Saharan Africa? Boston, MA: Population Association of America Annual Meeting; 2014; http://paa2014.princeton.edu/abstracts/140465 2014.
25. Papageorge N.Health, human capital, and domestic violence. Working Paper, 2015: https://nicholaswpapageorge.files.wordpress.com/2011/06/dv2.pdf.
26. Nelson RE, Nebeker JR, Hayden C, et al. Comparing adherence to two different HIV antiretroviral regimens: an instrumental variable analysis. AIDS Behav 2013; 17:160-167. doi:10.1007/s10461-012-0266-2.
27. Baird S, Gong E, McIntosh C, Ozler B. The heterogeneous effects of HIV testing. J Health Econ Elsevier B V 2014; 37C:98-112. doi:10.1016/j.jhealeco.2014.06.003.
28. Gong E. HIV testing & risky sexual behaviour. Econ J 2014; 125:32-60. doi:10.1111/ecoj.12125.
29. Thornton RL. The Demand for, and impact of, learning HIV status. Am Econ Rev 2008; 98:1829-1863. doi:10.1257/aer.98.5.1829.
30. Delavande A, Kohler H-P. The impact of HIV testing on subjective expectations and risky behavior in Malawi. Demography 2012; 49:1011-1036. doi:10.1007/s13524-012-0119-7.
31. Thirumurthy H, Zivin JG, Goldstein M. The economic impact of AIDS treatment: labor supply in western Kenya. J Hum Resour 2008; 43:511-552.
32. Larson BA, Fox MP, Rosen S, et al. Early effects of antiretroviral therapy on work performance: preliminary results from a cohort study of Kenyan agricultural workers. Aids 2008; 22:421.
33. Larson Ba. Fox MP, Rosen S, et al. Do the socioeconomic impacts of antiretroviral therapy vary by gender? A longitudinal study of Kenyan agricultural worker employment outcomes. BMC Public Health 2009; 9:240. doi:10.1186/1471-2458-9-240.
34. Habyarimana J, Mbakile B, Pop-Eleches C. The impact of HIV/AIDS and ARV treatment on worker absenteeism: implications for African firms. J Hum Resour 2010; 45:809-839. doi:10.1353/jhr.2010.0032.
35. Bor J, Tanser F, Newell M-L, Bärnighausen T. In a study of a population cohort in South Africa, HIV patients on antiretrovirals had nearly full recovery of employment. Health Aff 2012; 31:1459-1469. doi:10.1377/hlthaff.2012.0407.
36. Zivin JG, Thirumurthy H, Goldstein M. AIDS treatment and intrahousehold resource allocation: children's nutrition and schooling in Kenya. J Public Econ 2009; 93:1008-1015. doi:10.1016/j.jpubeco.2009.03.003.
37. Bor J, Tanser F, Newell M-L, et al. Economic spillover effects of ART on rural South African households. Washington DC, USA: IAEN 2012 (International AIDS and Economics Network Conference); 2012.
38. D'Adda G, Goldstein M, Zivin JG, et al. ARV treatment and time allocation to household tasks: evidence from Kenya. African Dev Rev 2009; 21:180-208. doi:10.1111/j.1467-8268.2009.00207.x.
39. Lucas AM, Wilson NL. Adult antiretroviral therapy and child health: evidence from scale-up in Zambia. Am Econ Rev 2013; 103:456-461. doi:10.1257/aer.103.3.456.
40. Bechange S, Bunnell R, Awor A, et al. Two-year follow-up of sexual behavior among HIV-uninfected household members of adults taking antiretroviral therapy in Uganda: no evidence of disinhibition. AIDS Behav 2010; 14:816-823.
41. McLaren Z. The effect of access to AIDS treatment on employment outcomes in South Africa. Essays on Labor Market Outcomes in South Africa 2010; Chapter 1, pp. 4-44. Dissertation: University of Michigan.
42. Barofsky J, Sood N, Wagner Z. HIV treatment and economic outcomes in Malawi. Boston, MA: Population Association of America Annual Meeting; 201.4
43. Lakdawalla D, Sood N, Goldman D. HIV breakthroughs and risky sexual behavior. Q J Econ 2006; 121:1063-1102.
44. De Walque D, Kazianga H, Over M. Antiretroviral therapy perceived efficacy and risky sexual behaviors: evidence from Mozambique. Econ Dev Cult Change 2012; 61:97-126.
45. Friedman W. Antiretroviral Drug Access and Behavior Change. 2014; http://willafriedman.com/documents/ARVaccessandbehaviorchange.pdf.
46. Bor J, McLaren Z, Tanser F, et al. HIV treatment as economic stimulus: community spillover effects of ART provision in rural South Africa. San Diego, CA: Population Association of America Annual Meeting; 2015.
47. Baranov V, Kohler H-P. The Impact of AIDS Treatment on Savings and Human Capital Investment in Malawi [Internet]. 2014. Report No.: 14-3. http://repository.upenn.edu/cgi/viewcontent.cgi?arti-cle=1054&context=psc-working-papers.
48. Wirth K, Bärnighausen T, Tanser F, Tchetgen E. Community-level antiretroviral therapy coverage and HIV acquisition in rural KwaZulu-Natal, South Africa: an instrumental variable analysis. Society for Epidemiologic Research, Denver, 16-19 June 2015.
49. Tanser F, Bärnighausen T, Grapsa E, et al. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 2013; 339:966-971. doi:10.1126/science. 1228160.
50. Zivin JG, Thirumurthy H, Goldstein M. AIDS treatment and intrahousehold resource allocation: children's nutrition and schooling in Kenya. J Public Econ 2009; 93:1008-1015.
51. Thirumurthy H, Zivin JG, Goldstein M. The economic impact of AIDS treatment. J Hum Resour 2008; 43:511.
52. De Walque D, Gertler PJ, Bautista-Arredondo S, et al. Using provider performance incentives to increase HIV testing and counseling services in Rwanda. J Health Econ 2014; 40C:1-9.
53. Goetz MB, Hoang T, Knapp H, et al. Central implementation strategies outperform local ones in improving HIV testing in Veterans Healthcare Administration facilities. J Gen Intern Med 2013; 28:1311-1317. doi:10.1007/s11606-013-2420-6.
54. McGovern M, Canning D, Tanser F, Herbst K, Gareta D, Mutevedzi T, et al. A Household Food Voucher Increases Consent to Home-Based HIV Testing in Rural KwaZulu-Natal. Conference on Retroviruses and Opportunistic Infections (CROI). Seattle, USA; 2015. http://www.croiconference.org/sessions/household-food-voucher-increases-consent-home-based-hiv-testing-rural-kwazulu-natal.
55. Klein PW, Messer LC, Myers ER, et al. Impact of a routine, opt-out HIV testing program on HIV testing and case detection in North Carolina sexually transmitted disease clinics. Sex Transm Dis 2014; 41:395-402. doi:10.1097/OLQ.0000000000000141.
56. Boruett P, Kagai D, Njogo S, et al. Facility-level intervention to improve attendance and adherence among patients on antiretroviral treatment in Kenya: a quasi-experimental study using time series analysis. BMC Health Serv Res 2013; 13:242. doi:10.1186/1472-6963-13-242.
57. De Neve J-W, Fink G, Subramanian SV, et al. Length of secondary schooling and risk of HIV infection in Botswana: evidence from a natural experiment. Lancet Glob Heal 2015; 3:e470-e477. doi:10.1016/S2214-109X(15)00087-X.
58. Burke M, Gong E, Jones K. Income shocks and HIV in Africa. Econ J 2014; 125:1157-1189.
59. Tsai A, Venkataramani A. The causal effect of education on HIV stigma in Uganda: evidence from a natural experiment. Social Science and Medicine 2015; 142:37-46.
60. Bärnighausen T, Bor J, Wandira-Kazibwe S, Canning D. Correcting HIV prevalence estimates for survey nonparticipation using Heckman-type selection models. Epidemiology 2011; 22:27-35. doi:10.1097/EDE.0-b013e3181ffa201.
61. McGovern ME, Bärnighausen T, Salomon JA, Canning D. Using interviewer random effects to remove selection bias from HIV prevalence estimates. BMC Med Res Methodol 2015; 15:8. doi:10.1186/1471-2288-15-8.
62. Moscoe E, Bor J, Bärnighausen T. Regression discontinuity designs are underutilized in medicine, epidemiology, and public health: a review of current and best practice. J Clin Epidemiol 2015; 68:122-133. doi:10.1016/j.jcli-nepi.2014.06.021.
63. Langlois EV, Ranson MK, Bärnighausen T, et al. Advancing the field of health systems research synthesis. Syst Rev 2015; 4:90. doi:10.1186/s13643-015-0080-9.